First volunteer receives Lassa fever vaccine in University of Oxford trial
The first human has been vaccinated with Oxford University's new Lassa fever vaccine in a major first‑in‑human trial
8 Dec 14:04 · Open Access Government
Oxford begins first human trial of new Lassa Fever vaccine
Thirty-one healthy adults aged 18 to 55 will take part in the trial in Oxford, while a second phase-1 trial is expected to begin in Ghana early 2026.
4 Dec 20:21 · Premium Times
last updated on 8 Dec 19:46